JP2000037452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000037452A5 JP2000037452A5 JP1998204545A JP20454598A JP2000037452A5 JP 2000037452 A5 JP2000037452 A5 JP 2000037452A5 JP 1998204545 A JP1998204545 A JP 1998204545A JP 20454598 A JP20454598 A JP 20454598A JP 2000037452 A5 JP2000037452 A5 JP 2000037452A5
- Authority
- JP
- Japan
- Prior art keywords
- ions
- acid ion
- organic acid
- peritoneal dialysis
- dialysis solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 chlor ions Chemical class 0.000 claims 9
- 239000000385 dialysis solution Substances 0.000 claims 3
- 239000011575 calcium Substances 0.000 claims 2
- 239000011777 magnesium Substances 0.000 claims 2
- 230000003204 osmotic effect Effects 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 229910001424 calcium ion Inorganic materials 0.000 claims 1
- 239000000539 dimer Substances 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 229940097043 glucuronic acid Drugs 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 229910001425 magnesium ion Inorganic materials 0.000 claims 1
- 229910001415 sodium ion Inorganic materials 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10204545A JP2000037452A (ja) | 1998-07-21 | 1998-07-21 | 腹膜透析液 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10204545A JP2000037452A (ja) | 1998-07-21 | 1998-07-21 | 腹膜透析液 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000037452A JP2000037452A (ja) | 2000-02-08 |
| JP2000037452A5 true JP2000037452A5 (enExample) | 2005-10-13 |
Family
ID=16492295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10204545A Pending JP2000037452A (ja) | 1998-07-21 | 1998-07-21 | 腹膜透析液 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000037452A (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770148B1 (en) | 1998-12-04 | 2004-08-03 | Baxter International Inc. | Peritoneal dialysis solution containing modified icodextrins |
| US8105258B2 (en) | 1999-04-26 | 2012-01-31 | Baxter International Inc. | Citrate anticoagulation system for extracorporeal blood treatments |
| US7186420B2 (en) | 1999-04-26 | 2007-03-06 | Edwards Lifesciences Corporation | Multi-part substitution infusion fluids and matching anticoagulants |
| AU4553700A (en) | 1999-04-26 | 2000-11-10 | Pe Chou Chang | Substitution infusion fluid and citrate anticoagulation |
| US7053059B2 (en) | 2003-07-25 | 2006-05-30 | Baxter International Inc. | Dialysis solutions with reduced levels of glucose degradation products |
| DE102004023828A1 (de) * | 2004-05-13 | 2005-12-08 | Fresenius Medical Care Deutschland Gmbh | Lösung für die Peritonealdialyse |
-
1998
- 1998-07-21 JP JP10204545A patent/JP2000037452A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007510758A5 (enExample) | ||
| TWI224007B (en) | Preparation containing glucose | |
| CA2250819A1 (en) | Solution for transperitoneal dialysis | |
| JP2003510243A5 (enExample) | ||
| SG66209A1 (en) | Peritoneal dialysis solutions containing maltodextrins and amino acids | |
| TR199500780A2 (tr) | Biyokimyasal olarak dengelenmis peritonal diyaliz solüsyonlari. | |
| JP2000037452A5 (enExample) | ||
| CA2339792A1 (en) | Opthalmic solution with tetracycline for topical treatment of dry eye disease | |
| ATE276765T1 (de) | Pharmazeutische und diätetische zusammensetzungen umfassend natrium-, kalium-, magnesium- und calciumionen und enzymaktivatoren | |
| CA2503154A1 (en) | A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid | |
| CA2601646A1 (en) | Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars | |
| CA2424968A1 (en) | Solution for peritoneal dialysis | |
| CA2470639A1 (en) | Preparation for wound healing and prevention of bandage adhesion to the wound | |
| JPH09301875A5 (enExample) | ||
| JP2003520252A5 (enExample) | ||
| CA2395209A1 (en) | Pack agent in a sheet form | |
| JP2001107078A5 (enExample) | ||
| Oster et al. | Hyporeninemic hypoaldosteronism after chronic sodium bicarbonate abuse | |
| RU97106720A (ru) | Способ лечения гемофтальма | |
| US20030134804A1 (en) | Rehydrating formulation | |
| CA2007387A1 (en) | Bowel lavage composition | |
| AU5024599A (en) | Pharmaceutical composition with antitumor activity on the basis of carboplatin | |
| GR1003607B (el) | Σκευασμα επιτραπεζιοy αλατος με μειωμενη περιεκτικοτητα σε χλωριoυχο νατριο και εμπλουτισμενο με αλατα μαγνησιου, καλιου και ασβeστιου | |
| RU2003125253A (ru) | Противовирусный лекарственный препарат | |
| UA36162A (uk) | Спосіб моделювання поліуричної форми гострої ниркової недостатності |